Skip to main content
. 2017 Aug 9;17:532. doi: 10.1186/s12885-017-3495-y

Fig. 6.

Fig. 6

Concomitant treatment of RMS with chemotherapeutics (vincrsitine, actinomycin D and cisplatin) and subtoxic concentration of PPP (0.1 μM). RH30 and RD cells were simultaneously treated with indicated doses of chemotherapeutics and proliferation potential was assayed. (VCR – vincristine, CDDP – cisplatin, ACTD – actinomycin D). All experiments were repeated three times with similar results. *p < 0.05